Literature DB >> 1601078

Antibiotic sensitivities of Neisseria meningitidis isolates from patients and carriers in Greece.

G Tzanakaki1, C C Blackwell, J Kremastinou, C Kallergi, G Kouppari, D M Weir.   

Abstract

Usage of antibiotics in southern Europe is less well regulated than in northern countries. The proportion (48%) of meningococci in Spain insensitive to pencillin (MIC greater than or equal to 0.1 mg/l) prompted this investigation of antibiotic sensitivities of isolates from Greek patients with meningitis (31) and carriers (47 school-children and 472 recruits). The agar dilution method was used to determine MIC to penicillin G (PN), sulphamethoxazole (SU), rifampicin (RF), cefaclor (CF) and ciprofloxacin (CP). The proportion of isolates insensitive to PN was 48% for isolates from patients, 19% from school-children and 36.6% from recruits. Resistance to SU (MIC greater than or equal to 16 mg/l) was found in 16% of those from patients, 10.6% from children and 40% from recruits. None of the isolates from patients was resistant to RF (greater than or equal to 1 mg/l) but 6% of those from carriers were. Resistance to CF (greater than or equal to 4 mg/l) was found in 9.2% of patient isolates, 6.4% from children and 23.7% from recruits. All isolates except one were sensitive to CP (MIC range less than 0.0015-0.125 mg/l). Resistances to PN, SU and RF were analysed by serogroup, serotype and subtype of the bacteria. The proportion of resistant isolates showed some variation between different areas of Greece, but it was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601078      PMCID: PMC2272217          DOI: 10.1017/s0950268800049955

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  12 in total

1.  Meningococci moderately resistant to penicillin.

Authors:  J A Saez Nieto; J A Vazquez; C Marcos
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

2.  Meningococci with reduced susceptibility to penicillin.

Authors:  D M Jones; E M Sutcliffe
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

3.  Serological classification in relation to auxotypes, plasmid contents, and susceptibilities to antimicrobials of PPNG and non-PPNG strains isolated in Greece.

Authors:  G Tzanakaki; L Mavrommati; E Tzelepi; S Kolyva; E Fragouli
Journal:  Genitourin Med       Date:  1989-06

4.  Penicillin-insensitive meningococci in the UK.

Authors:  E M Sutcliffe; D M Jones; S el-Sheikh; A Percival
Journal:  Lancet       Date:  1988-03-19       Impact factor: 79.321

5.  Penicillin-resistant Neisseria meningitidis in southern Africa.

Authors:  P Botha
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

6.  Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrations.

Authors:  J A Sáez-Nieto; D Fontanals; J Garcia de Jalon; V Martinez de Artola; P Peña; M A Morera; R Verdaguer; I Sanfeliu; C Belio-Blasco; J L Perez-Saenz
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

7.  Factors affecting carriage of Neisseria meningitidis among Greek military recruits.

Authors:  C C Blackwell; G Tzanakaki; J Kremastinou; D M Weir; N Vakalis; R A Elton; A Mentis; N Fatouros
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

8.  High-level tetracycline resistance resulting from TetM in strains of Neisseria spp., Kingella denitrificans, and Eikenella corrodens.

Authors:  J S Knapp; S R Johnson; J M Zenilman; M C Roberts; S A Morse
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

9.  Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis.

Authors:  P N Gaunt; B E Lambert
Journal:  J Antimicrob Chemother       Date:  1988-04       Impact factor: 5.790

10.  The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica.

Authors:  K A Cartwright; J M Stuart; D M Jones; N D Noah
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

View more
  8 in total

1.  First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia.

Authors:  A Boras; D Bozinovic; F C Tenover; T Popovic
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Complete sequence of a beta-lactamase-encoding plasmid in Neisseria meningitidis.

Authors:  A Bäckman; P Orvelid; J A Vazquez; O Sköld; P Olcén
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

3.  E test as susceptibility test for evaluation of Neisseria meningitidis isolates.

Authors:  E Pérez-Trallero; N Gomez; J M García-Arenzana
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

4.  Decreased susceptibility to penicillin G and Tet M plasmids in genital and anorectal isolates of Neisseria meningitidis.

Authors:  K K Winterscheid; W L Whittington; M C Roberts; J R Schwebke; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

5.  In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis.

Authors:  Tiffany R Shultz; Peter A White; John W Tapsall
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 6.  Acute bacterial meningitis in infants and children: epidemiology and management.

Authors:  Shruti Agrawal; Simon Nadel
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

7.  In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.

Authors:  J M Blondeau; Y Yaschuk
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Shifts in the Antibiotic Susceptibility, Serogroups, and Clonal Complexes of Neisseria meningitidis in Shanghai, China: A Time Trend Analysis of the Pre-Quinolone and Quinolone Eras.

Authors:  Mingliang Chen; Qinglan Guo; Ye Wang; Ying Zou; Gangyi Wang; Xi Zhang; Xiaogang Xu; Miao Zhao; Fupin Hu; Di Qu; Min Chen; Minggui Wang
Journal:  PLoS Med       Date:  2015-06-09       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.